DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease

DaVita (NYSE:DVA) announced a new value-based care agreement with Humana to deliver comprehensive, coordinated care for more than 10,000 Humana Medicare Advantage members with chronic kidney disease (CKD) stages 3B–5.

Rhea-AI Summary

DaVita (NYSE:DVA) announced a new value-based care agreement with Humana to deliver comprehensive, coordinated care for more than 10,000 Humana Medicare Advantage members with chronic kidney disease (CKD) stages 3B–5. Launched July 1, the partnership expands the companies’ long-standing collaboration in end stage kidney disease to earlier stages, where interventions are intended to have greater impact.

Care is delivered through DaVita Integrated Kidney Care, which provides whole-person, coordinated management of cardiovascular, kidney and metabolic health, aiming to reduce care fragmentation and avoidable hospitalizations. The model leverages DaVita’s network of 3,000 value-based nephrologist partners and offers interdisciplinary support, education on home dialysis and kidney transplantation, and help with barriers such as nutrition, transportation and mental health as patients approach potential kidney failure.

Positive

• New value-based care agreement with Humana for CKD stages 3B–5
• Program covers more than 10,000 Humana Medicare Advantage members
• Model supported by 3,000 value-based nephrologist partners in DaVita’s network

Negative

• None.

Argus Aug 25 session

+0.72% close to close Open Argus

Details

News Market Reaction – DVA

On Aug 25, the day this news came out, DVA closed 0.72% above the previous close.

Data tracked by StockTitan Argus for the Aug 25 session.

Key Figures

Patients Served: more than 10,000 patients CKD Stages: stages 3B–5 Partnership Launch: July 1 +1 more

Patients Served

more than 10,000 patients

Humana Medicare Advantage partnership

CKD Stages

stages 3B–5

対象 chronic kidney disease population

Partnership Launch

July 1

Value-based care agreement

Nephrologist Partners

3,000 value-based nephrologist partners

DaVita network

Historical Context

5 past events · Latest: Aug 04

5 events

1. Aug 04

   2Q26 earnings

   24h Move

   -17.2%

   Reported quarterly revenue, earnings, cash flow and 2026 guidance before a 17.24% decline.

2. Jul 21

   Earnings scheduling

   24h Move

   -2.2%

   Scheduled the second-quarter results conference call and release for August 4.

3. May 18

   Community commitments

   24h Move

   -0.1%

   Announced 2030 community care commitments after exceeding most prior five-year ESG goals.

4. May 06

   Conference participation

   24h Move

   +1.2%

   Announced executive participation in the BofA Securities Health Care Conference.

5. May 05

   1Q26 earnings

   24h Move

   +23.5%

   Reported first-quarter results and share repurchases before a 23.46% increase.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

ckd, value-based care, medicare advantage, home dialysis

4 terms

ckd medical

"members with chronic kidney disease (CKD) stages 3B–5"

Chronic kidney disease (CKD) is a long-term condition where the kidneys gradually lose their ability to filter waste and fluids from the blood, like household filters that slowly clog and underperform over time. It matters to investors because CKD drives demand for drugs, medical devices, diagnostics and dialysis services, influences healthcare spending and reimbursement decisions, and creates regulatory or clinical-trial risks and market opportunities across the healthcare sector.

value-based care financial

"announced a new value-based care agreement"

A health-care delivery approach that rewards providers for keeping patients healthy and improving outcomes instead of charging for each test or visit. For investors, it matters because it shifts where profits and losses come from—favoring providers and technologies that lower long-term costs, prevent complications, and demonstrate measurable results; think of it like paying a contractor only when the house stays sound, which changes who wins and loses financially.

medicare advantage regulatory

"Humana Medicare Advantage members with chronic kidney disease"

Medicare Advantage is a type of health insurance plan offered by private companies that covers services traditionally provided by government-run Medicare. Think of it as a bundled package that combines hospital, doctor, and other medical care into one plan, often with added benefits. For investors, it matters because the popularity and profitability of these plans can influence healthcare companies and the broader health insurance industry.

home dialysis medical

"including home dialysis and kidney transplantation"

Home dialysis is a way for kidney patients to perform blood-cleaning treatments at or near their residence instead of at a hospital or clinic, using machines or a simpler fluid-exchange method supervised remotely or by a caregiver. For investors it signals a shift in care delivery that can lower long-term costs, increase patient choice and uptime, and create recurring revenue opportunities for device makers, software providers and service firms—much like moving from dining out to regular home cooking changes demand for restaurants and groceries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

More than 10,000 members will get added support aimed at delaying or preventing dialysis and reducing hospitalizations

DENVER, Aug. 25, 2026 /PRNewswire/ -- DaVita today announced a new value-based care agreement to deliver comprehensive, coordinated care to Humana Medicare Advantage members with chronic kidney disease (CKD) stages 3B–5.

Launched July 1, this partnership builds on the organizations' long-standing collaboration in end stage kidney disease and expands earlier into the disease journey, when intervention can have the greatest impact.

As the healthcare system aims for more impactful, value-based, preventive care, DaVita continues to lead in managing complex chronic conditions earlier. Through DaVita Integrated Kidney Care (DaVita IKC), patients receive coordinated, whole-person care that addresses the interconnected nature of cardiovascular, kidney and metabolic health — reducing fragmentation and avoidable hospital admissions.

"We are in a therapeutic revolution across kidney care where upstream interventions are helping to reshape patient outcomes," said Dr. Sonia Samagh, national medical director for DaVita IKC. "Through our partnership with Humana, we are deploying advanced care that treats the whole patient, preserves kidney function and serves as a central hub for managing comorbid conditions affecting kidney health."

This model builds upon the experience of DaVita's extensive network of 3,000 value-based nephrologist partners. Through continued collaboration and innovation alongside these specialists, DaVita aims to drive deeper patient engagement, impactful clinical outcomes and an unmatched care experience.

The partnership will serve more than 10,000 patients.

Intervening Earlier in Disease Progression

The program focuses on CKD patients beginning at a pivotal point when kidney decline often accelerates but remains underdiagnosed or undertreated. By engaging patients earlier and more consistently, the model is designed to stabilize kidney function and slow disease progression.

Closing Gaps in Care for Patients with Complex Conditions

Not every patient can avoid kidney failure, despite the best clinical interventions. When that happens, advanced and coordinated care helps patients prepare for the next stage of their health journey through early education, advance care planning and coordinated support. Patients receive guidance on treatment options, including home dialysis and kidney transplantation, and are supported by an interdisciplinary care team that helps address barriers to care such as nutrition, transportation and mental health needs, enabling a smoother transition and better patient experience.

"The kidneys are often an early indicator that something else is happening systemically within the body. To truly care for the kidneys, we must uncover and address those underlying health issues," said Dr. Samagh. "When we do this, we can work to preserve kidney function, support reduced hospitalizations and enhance patients' quality of life."

About DaVita Inc.

DaVita (NYSE: DVA) is a healthcare provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 25 years. DaVita cares for patients at every stage and setting along their kidney health journey — from slowing the progression of kidney disease to helping support transplantation. This includes ensuring they are supported at home, in dialysis centers, in the hospital and in skilled nursing facilities. As of June 30, 2026, DaVita served approximately 298,500 patients at 3,266 outpatient dialysis centers, of which 2,671 centers were located in the United States and 595 centers were located in 14 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Media Contacts

DaVita Newsroom
newsroom@davita.com       

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-announces-new-value-based-partnership-with-humana-to-expand-care-for-patients-with-chronic-kidney-disease-302858582.html

SOURCE DaVita

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is DaVita (DVA)'s new value-based partnership with Humana announced on August 25, 2026?

DaVita announced a value-based care agreement with Humana to deliver coordinated care for Medicare Advantage members with CKD stages 3B–5. According to DaVita, the model focuses on whole-person, preventive management to stabilize kidney function and reduce avoidable hospitalizations.

How many Humana Medicare Advantage members with CKD are covered by DaVita's (DVA) new agreement?

The program will serve more than 10,000 Humana Medicare Advantage members with CKD stages 3B–5. According to DaVita, these patients gain access to comprehensive, coordinated kidney care designed to delay or prevent dialysis and support reduced hospitalizations.

When did DaVita (DVA) and Humana launch their new CKD value-based care program?

The new value-based care program for Humana Medicare Advantage members with CKD stages 3B–5 launched on July 1. According to DaVita, this start date marks an expansion of their earlier collaboration in end stage kidney disease into earlier CKD stages.

How does DaVita Integrated Kidney Care support CKD stages 3B–5 under the Humana partnership?

DaVita Integrated Kidney Care provides coordinated, whole-person care addressing cardiovascular, kidney and metabolic health for CKD stages 3B–5. According to DaVita, this approach reduces care fragmentation and is designed to stabilize kidney function and slow disease progression for participating Humana members.

What support do DaVita (DVA) and Humana offer when patients progress to kidney failure?

Patients who reach kidney failure receive advanced, coordinated support including early education, advance care planning and treatment-option guidance. According to DaVita, interdisciplinary teams help patients evaluate home dialysis and transplantation and address barriers like nutrition, transportation and mental health needs.

How many nephrologist partners are involved in DaVita's value-based care model with Humana?

The model builds on DaVita’s network of 3,000 value-based nephrologist partners. According to DaVita, ongoing collaboration with these specialists is intended to deepen patient engagement, support impactful clinical outcomes and enhance the overall care experience for Humana Medicare Advantage members.